Exploration of target genes of HOXA13 in esophageal squamous cell carcinoma cell line

Cancer Letters

Volumn 312, Issue 1, 2011, Pages 18-23

  Shen, Lu Yan ^a   Chen, Ke Neng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

CHIP DSL; Esophageal squamous cell carcinoma; HOXA13; Proteomics

Indexed keywords

GENE PRODUCT; HOMEODOMAIN PROTEIN; LIPOCORTIN 2; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN ERAB; PROTEIN HOXA13; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; GENE EXPRESSION; HOMEOBOX; HOXA13 GENE; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESOPHAGEAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSCRIPTIONAL ACTIVATION;

EID: 80053314255     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.020     Document Type: Article

References (25)

1. Pisani P., Parkin D.M., Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int. J. Cancer 1993, 55:891-903.
2. Macfarlane G.J., Boyle P. The epidemiology of oesophageal cancer in the UK and other European countries. J. R. Soc. Med. 1994, 87:334-337.
3. Grier D.G., Thompson A., Kwasniewska A., McGonigle G.J., Halliday H.L., Lappin T.R. The pathophysiology of HOX genes and their role in cancer. J. Pathol. 2005, 205(2):154-171.
4. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence?. Nat. Rev. Cancer 2002, 2(10):777-785.
5. Chen K.N., Gu Z.D., Ke Y., Li J.Y., Shi X.T., Xu G.W. Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma. Clin. Cancer Res. 2005, 11(3):1044-1049.
6. Gu Z.D., Shen L.Y., Wang H., Chen X.M., Li Y., Ning T., Chen K.N. HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma. Cancer Res. 2009, 69(12):4969-4973.
7. Benz J., Hofmann A. Annexins: from structure to function. Biol. Chem. 1997, 378(3-4):177-183.
8. Vishwanatha J.K., Chiang Y.P., Kumble K.D., Hollingsworth M.A., Pour P.M. Enhanced expression of Annexin-II in human pancreatic-carcinoma cells and primary pancreatic cancers. Carcinogenesis 1993, 14(12):2575-2579.
9. Cesarman G.M., Guevara C.A., Hajjar K.A. An endothelial-cell receptor for plasminogen tissue-plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J. Biol. Chem. 1994, 269(33):21198-21203.
10. Hajjar K.A., Jacovina A.T., Chacko J. An endothelial-cell receptor for plasminogen tissue-plasminogen activator. I. Identity with Annexin-II. J. Biol. Chem. 1994, 269(33):21191-21197.
11. Kassam G., Choi K.S., Ghuman J., Kang H.M., Fitzpatrick S.L., Zackson T., Zackson S., Toba M., Shinomiya A., Waisman D.M. The role of Annexin II tetramer in the activation of plasminogen. J. Biol. Chem. 1998, 273(8):4790-4799.
12. Ortiz-Zapater E., Peiro S., Roda O., Corominas J.M., Aguilar S., Ampurdanes C., Real F.X., Navarro P. Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and Annexin A2. Am. J. Pathol. 2007, 170(5):1573-1584.
13. Buetler T.M., Krauskopf A., Ruegg U.T. Role of superoxide as a signaling molecule. News Physiol. Sci. 2004, 19:120-123.
14. Werner E. GTPases and reactive oxygen species: switches for killing and signaling. J. Cell Sci. 2004, 117:143-153.
15. Eblin K.E., Jensen T.J., Wnek S.M., Buffington S.E., Futscher B.W., Gandolfi A.J. Reactive oxygen species regulate properties of transformation in UROtsa cells exposed to monomethylarsonous acid by modulating MAPK signaling. Toxicology 2009, 255(1-2):107-114.
16. Mohr A., Büneker C., Gough R.P., Zwacka R.M. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. Oncogene 2008, 27(6):763-774.
17. Fukai T., Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function and diseases. Antioxid. Redox Signal. 2011, 15(6):1583-1606.
18. Quirós I., Sáinz R.M., Hevia D., García-Suárez O., Astudillo A., Rivas M., Mayo J.C. Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells. Int. J. Cancer 2009, 125(7):1497-1504.
19. Pani Giovambattista, Colavitti Renata, Bedogni Barbara, Fusco Salvatore, Ferraro Daniela, Borrello Silvia, Galeotti Tommaso Mitochondrial superoxide dismutase a promising target for new anticancer therapies. Curr. Medicinal Chem. 2004, 11:1299-1308.
20. K. Brennan, G. Offiah, E.A. McSherry, A.M. Hopkins, Tight junctions: a barrier to the initiation and progression of breast cancer? J. Biomed. Biotechnol., doi:1155/2010/460607.
21. Wagner E.F., Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 2009, 9(8):537-549.
22. Lai S.L., Chien A.J., Moon R.T. Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis. Cell Res. 2009, 19(5):532-545.
23. Tian M., Neil J.R., Schiemann W.P. Transforming growth factor-β and the hallmarks of cancer. Cell. Signal. 2011, 23(6):951-962.
24. Stamatakos M., Palla V., Karaiskos I., Xiromeritis K., Alexiou I., Pateras I., Kontzoglou K. Cell cyclins: triggering elements of cancer or not?. World J. Surg. Oncol. 2010, 8:111.
25. Cronier Laurent, Crespin Sophie, Strale Pierre-Olivier, Defamie Norah, Mesnil Marc Gap junctions and cancer new functions for an old story. Antioxid. Redox Signal. 2009, 11(2):323-338.